Unicycive Therapeutics
Tracked across 2 events · 71 articles · First seen Aug 21, 2025 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Unicycive Therapeutics is the subject of a securities investigation following a second FDA Complete Response Letter for its OLC NDA, causing a stock price decline.
Jun 30, 2026 · 13 articles
Regulatory
Multiple investor-rights law firms have filed or announced securities fraud class action lawsuits against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers on behalf of investors who acquired Unicycive securities between December 29,…
Impact: Unicycive is the defendant and central subject of the securities fraud class action, facing allegations of misleading investors about third-party manufacturing deficiencies and the resulting FDA Complete Response Letter for oxylanthanum carbonate. The stock reportedly fell 39.1% on the CRL disclosure, and the litigation adds legal costs and reputational damage.
Sep 03, 2026 · 58 articles
100
Unicycive Therapeutics disclosed FDA CRLUnicycive Securities Fraud...
100
Bronstein, Gewirtz & Grossman, LLC filed class action Unicycive TherapeuticsUnicycive Securities Fraud...
100
United States — Food and Drug Administration issued CRL Unicycive TherapeuticsUnicycive Securities Fraud...
95
Unicycive Therapeutics announced second Complete Response LetterUnicycive Securities Fraud...
90
Schall Brown & Schwartz LLP filed class action lawsuit Unicycive TherapeuticsUnicycive Securities Fraud...
80
Unicycive Therapeutics failed to discloseUnicycive Securities Fraud...
80
Glancy Prongay & Murray filed securities fraud lawsuit Unicycive TherapeuticsUnicycive Securities Fraud...
80
The Law Offices of Frank R. Cruz filed securities fraud lawsuit Unicycive TherapeuticsUnicycive Securities Fraud...
80
Levi & Korsinsky filed securities class action Unicycive TherapeuticsUnicycive Securities Fraud...
75
Unicycive Therapeutics made misleading statementsUnicycive Securities Fraud...
70
Unicycive Therapeutics resubmitted New Drug Application United States — Food and Drug AdministrationUnicycive Securities Fraud...
70
Rosen Law Firm filed class action lawsuit Unicycive TherapeuticsUnicycive Securities Fraud...
65
United States — Food and Drug Administration issued Complete Response Letter Unicycive TherapeuticsUnicycive Securities Fraud...
60
United States — Food and Drug Administration cited deficiencies Unicycive TherapeuticsUnicycive Securities Fraud...
60
United States — Food and Drug Administration accepted resubmission Unicycive TherapeuticsUnicycive Securities Fraud...
45
Unicycive Therapeutics projected review on trackUnicycive Securities Fraud...
ERGEN INTELLIGENCE
Track Unicycive Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard